Bone : Joints : Connective Tissue


Joints, Cartilage & Connective Tissue


With approximately 1 in 3 adults in the US between 25 and 74 years of age showing radiological evidence of Osteoarthritis (OA) in at least one joint, it should come as no surprise that OA is the most common joint disorder and the leading cause of joint disability. While more pervasive in older adults, degenerative joint disease (DJD) is not an inevitable consequence of growing older. It develops when trauma, and/or biochemical changes trigger a shift between joint cartilage synthesis and degradation.

Essentially, when the cartilage synthesis of any joint cannot keep pace with the background degradation of the cartilage, the joint will degenerate.
Two very important factors play a primary role in joint deterioration: 
(1) the reduction in proteoglycan production in the joint cartilage, and 
(2) the rate of production of inflammatory catabolic cytokines in the chondrocytes and synovial cells.

While genetics, diet, and trauma contribute significantly to the development of Osteoarthritis, supporting the joint cartilage matrix and connective tissue with specific nutraceuticals may prove beneficial in reducing further damage and restoring joint mobility.*

For nutraceutical OA support, consider:
Bio-Flex II for all-in-one joint support
• Consider Inflam-95Maximum G-C-M II, and Mito-Detox III to Reduce-Restore-Repair in advanced cases of OA*
• Essential fatty acids, available in various concentrations of Omega3's


Bone Density
In addition to Calcium for optimal bone health, consider the benefits of Magnesium and Glycine for additional benefits kidney function.

For nutraceutical OPO support, consider:
• Bio-Flex II for all-in-one joint support

> MORE about Joint Health - Osteoarthritis (OA), Reduce-Restore-Repair
> MORE about Bone Health - Osteoporosis (OPO), Osteo-Max brochure (sign in)
1